Riccardo Roversi advised the seller on the sale of a controlling stake in the Swiss pharmaceutical company Rivopharm SA.

Riccardo Roversi advised the seller on the sale of a controlling stake in the Swiss pharmaceutical company Rivopharm SA.
Thanks to this transaction, Rivopharm enters the orbit of an international industrial player that will support its international expansion.

Osborne Clarke’s Amsterdam office advised on the Dutch law aspects of the transaction.

The seller was also advised by the Milan office of White & Case, while the buyer was advised by A&O Sherman.

Rivopharm is a pharmaceutical company that has been operating since 1961, with its headquarters in the Canton of Ticino and subsidiaries in Germany, the United Kingdom, and Lithuania.